欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1126/003
药品名称
Ceftazidima Hikma
活性成分
Ceftazidime pentahydrate 2000.0 mg
剂型
Powder for solution for infusion/injection
上市许可持有人
Hikma Farmacêutica (Portugal), S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Ceftazidim Hikma 2 g, Pulver zur Herstellung einer Injektionslösung
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
许可日期
2014/06/11
最近更新日期
2024/11/21
药物ATC编码
J01DD02 ceftazidime
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
common_spc_ceftazidime_dcp_var017_tracked
Date of last change:2024/11/21
Final PL
|
common_pl_ceftazidime_dcp_var017_tracked
Date of last change:2024/11/21
Final Labelling
|
common_outer_ceftazidimeallstrengths _clean_
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase